Form 4 for ISRG Intuitive Surgical
Accepted 2024-10-31 00:00:00 ET · period of report 2024-10-30 · accession 0001035267-24-000257 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-10-31 | 2024-10-30 | ISRG | GUTHART GARY S | CEO, Dir | S - Sale+OE | $510.63 | -7,440 | 19.9K | -27% | -$3.80M |
| D | 2024-10-31 | 2024-10-30 | ISRG | GUTHART GARY S | CEO, Dir | M - OptEx | $59.23 | +25.2K | 42.4K | +147% | +$1.49M |
| D | 2024-10-31 | 2024-10-30 | ISRG | GUTHART GARY S | CEO, Dir | S - Sale+OE | $511.63 | -18.2K | 24.2K | -43% | -$9.29M |
| D | 2024-10-31 | 2024-10-30 | ISRG | GUTHART GARY S | CEO, Dir | M - OptEx | $0.00 | -25.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-30 | S | D | 3,720 | $510.75 | 19,920 | I | — | — | (F4) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $508.52 to $516.67 as follows: 388 shares sold at $508.52 to $509.06; 1,698 shares sold at $509.53 to $510.49; 1,155 shares sold at $510.63 to $511.54; 215 shares sold at $511.84 to $512.76; and 264 shares sold at $516.31 to $516.67. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-10-30 | M | A | 25,200 | $59.23 | 42,370 | D Trust FBO Daughter | — | — | |
| 3 | Common | Common Stock | 2024-10-30 | S | D | 18,151 | $511.63 | 24,219 | D Trust FBO Son | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $508.66 to $516.87 as follows: 1,504 shares sold at $508.66 to $509.50; 8,289 shares sold at $509.67 to $510.63; 3,083 shares sold at $510.68 to $511.54; 775 shares sold at $511.91to $512.30; 599 shares sold at $513.14 to $514.09; 1,728 shares sold at $514.28 to $515.26; 274 shares sold at $515.38 to $515.99; and 1,899 shares sold at $516.56 to $516.87. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2024-10-30 | S | D | 3,720 | $510.52 | 19,920 | I | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $508.51 to $516.31 as follows: 415 shares sold at $508.51 to $509.24; 1,993 shares sold at $509.53 to $510.49; 693 shares sold at $510.54 to $510.93; 320 shares sold at $511.57 to $512.22; 127 shares sold at $512.61 to $512.74; 100 shares sold at $514.47; and 72 shares sold at $516.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-10-30 | M | D | 25,200 | $0.00 | 0 | D | $59.23 · — to 2025-08-17 | 25,200 Common Stock | (F5) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |